Back to Peptides
Longevity
FOXO4-DRI
FOXO4-DRI is an experimental senolytic peptide designed to disrupt the FOXO4-p53 interaction, selectively triggering apoptosis in senescent cells. It is an early-stage research compound studied in preclinical models for its potential longevity effects.
LongevitySenolyticExperimentalResearch Only
Research Benefits
Senolytic clearance of senescent cells studied
FOXO4-p53 disruption mechanism characterized
Tissue-function outcomes in preclinical models
Course-based experimental protocols
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for FOXO4-DRI — and how mature that evidence is.